Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts 5 Best-performing Canadian Uranium Stocks of 2025 August 6, 2025 Bitcoin: A Price History of the First Cryptocurrency August 6, 2025 Stallion Uranium Announces Flow-Through and Non-Flow Through Private Placements for Gross Proceeds of up to $12M August 6, 2025
Stallion Uranium Announces Flow-Through and Non-Flow Through Private Placements for Gross Proceeds of up to $12M August 6, 2025